Literature DB >> 8243797

Cloning and functional characterisation of the human TRH receptor.

S M Duthie1, P L Taylor, L Anderson, J Cook, K A Eidne.   

Abstract

Thyrotrophin-releasing hormone (TRH) is a hypothalamic tripeptide known to act via its receptor in the anterior pituitary gland to stimulate the release of thyrotrophin (TSH) from thyrotrophs and prolactin (PRL) from lactotrophs. It is also thought to act as a neurotransmitter/neuromodulator in the central and peripheral nervous systems. We have isolated a cDNA encoding the human pituitary TRH receptor (TRH-R) protein with a predicted amino acid sequence of 398 amino acids. Comparison of the amino acid sequences of the human TRH-R with the previously published rodent TRH-Rs showed that it is similar to both the rat and mouse TRH-Rs, except that each species has variant amino acids at the carboxy (COOH) terminus. The human TRH-R belongs to the family of seven transmembrane domain, G-protein-coupled receptors, and it is believed that the COOH terminal region of this family of receptors may play an important role in receptor downregulation/internalisation, and possibly G-protein coupling. COS-1 cells expressing the human TRH-R showed high affinity receptor binding. Stimulation of these cells with TRH produced a typical phosphoinositide response and mobilisation of intracellular calcium [Ca2+]i.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8243797     DOI: 10.1016/0303-7207(93)90043-j

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  9 in total

Review 1.  MRNA stability and the control of gene expression: implications for human disease.

Authors:  Elysia M Hollams; Keith M Giles; Andrew M Thomson; Peter J Leedman
Journal:  Neurochem Res       Date:  2002-10       Impact factor: 3.996

Review 2.  Genetic aspects of central hypothyroidism.

Authors:  R Collu
Journal:  J Endocrinol Invest       Date:  2000-02       Impact factor: 4.256

3.  Evolutionarily conserved TRH neuropeptide pathway regulates growth in Caenorhabditis elegans.

Authors:  Elien Van Sinay; Olivier Mirabeau; Geert Depuydt; Matthias Boris Van Hiel; Katleen Peymen; Jan Watteyne; Sven Zels; Liliane Schoofs; Isabel Beets
Journal:  Proc Natl Acad Sci U S A       Date:  2017-05-01       Impact factor: 11.205

4.  Synthesis, receptor binding, and CNS pharmacological studies of new thyrotropin-releasing hormone (TRH) analogues.

Authors:  Vikramdeep Monga; Chhuttan L Meena; Satyendra Rajput; Chandrashekhar Pawar; Shyam S Sharma; Xinping Lu; Marvin C Gershengorn; Rahul Jain
Journal:  ChemMedChem       Date:  2011-02-07       Impact factor: 3.466

5.  Genetic complexity of an obesity QTL ( Fob3) revealed by detailed genetic mapping.

Authors:  Ioannis M Stylianou; Julian K Christians; Peter D Keightley; Lutz Bünger; Michael Clinton; Grahame Bulfield; Simon Horvat
Journal:  Mamm Genome       Date:  2004-06       Impact factor: 2.957

6.  Assignment of the gene encoding the human thyrotropin-releasing hormone receptor to 8q23 by fluorescence in situ hybridization.

Authors:  N Morrison; S M Duthie; E Boyd; K A Eidne; J M Connor
Journal:  Hum Genet       Date:  1994-06       Impact factor: 4.132

7.  Rapid desensitization of the thyrotropin-releasing hormone receptor expressed in single human embryonal kidney 293 cells.

Authors:  L Anderson; C L Alexander; E Faccenda; K A Eidne
Journal:  Biochem J       Date:  1995-10-15       Impact factor: 3.857

Review 8.  Biochemical and physiological insights into TRH receptor-mediated signaling.

Authors:  Radka Trubacova; Zdenka Drastichova; Jiri Novotny
Journal:  Front Cell Dev Biol       Date:  2022-09-06

9.  TRH-receptor-type-2-deficient mice are euthyroid and exhibit increased depression and reduced anxiety phenotypes.

Authors:  Yuhua Sun; Bojana Zupan; Bruce M Raaka; Miklos Toth; Marvin C Gershengorn
Journal:  Neuropsychopharmacology       Date:  2008-12-10       Impact factor: 7.853

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.